mercaptopurine and Esophageal-Stenosis

mercaptopurine has been researched along with Esophageal-Stenosis* in 2 studies

Other Studies

2 other study(ies) available for mercaptopurine and Esophageal-Stenosis

Article	Year
Chemotherapy induced esophageal stricture. Pediatric blood & cancer, 2009, Volume: 52, Issue:4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Down Syndrome; Esophageal Stenosis; Esophagectomy; Humans; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Tretinoin	2009
[A case of acute promyelocytic leukemia complicated with severe esophageal stenosis caused by aclacinomycin A]. Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:8 Aclacinomycin A (ACM) is different from other anthracycline antibiotics in its antitumor activity and clinical effect. We report a case of acute promyelocytic leukemia complicated with severe esophageal ulcer by BH-AC . AMP therapy. The patient was 24 years old. In 1983, he achieved complete remission with BH-AC . DMP therapy but we confirmed relapse in April, 1984. ACM caused nausea, vomiting, diarrhea, alimentary tract bleeding and sore throat, together with a complication of esophageal stenosis. In about half of 10 cases receiving BH-AC . AMP therapy in our hospital, we noticed severe bleeding in the urinary treat, genital organs and alimentary tract. Care should therefore be taken with regard to mucosal injury when ACM therapy is used. Topics: Aclarubicin; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Esophageal Stenosis; Esophagoscopy; Humans; Leukemia, Lymphoid; Male; Mercaptopurine; Naphthacenes; Prednisolone	1985

Article

Year

Chemotherapy induced esophageal stricture.

Pediatric blood & cancer, 2009, Volume: 52, Issue:4

Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Down Syndrome; Esophageal Stenosis; Esophagectomy; Humans; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Tretinoin

2009

[A case of acute promyelocytic leukemia complicated with severe esophageal stenosis caused by aclacinomycin A].

Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:8

Aclacinomycin A (ACM) is different from other anthracycline antibiotics in its antitumor activity and clinical effect. We report a case of acute promyelocytic leukemia complicated with severe esophageal ulcer by BH-AC . AMP therapy. The patient was 24 years old. In 1983, he achieved complete remission with BH-AC . DMP therapy but we confirmed relapse in April, 1984. ACM caused nausea, vomiting, diarrhea, alimentary tract bleeding and sore throat, together with a complication of esophageal stenosis. In about half of 10 cases receiving BH-AC . AMP therapy in our hospital, we noticed severe bleeding in the urinary treat, genital organs and alimentary tract. Care should therefore be taken with regard to mucosal injury when ACM therapy is used.

Topics: Aclarubicin; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Esophageal Stenosis; Esophagoscopy; Humans; Leukemia, Lymphoid; Male; Mercaptopurine; Naphthacenes; Prednisolone

1985